Abdominal Fat Is Directly Associated With Inflammation In Persons With Type-2 Diabetes Regardless Of Glycemic Control - A Jordanian Study

被引:10
作者
Bawadi, Hiba [1 ]
Katkhouda, Rami [2 ]
Tayyem, Reema [3 ]
Kerkadi, Abdelhamid [1 ]
Raad, Samira Bou [4 ]
Subih, Hadil [2 ]
机构
[1] Qatar Univ, Coll Hlth Sci, Human Nutr Dept, QU Hlth, Bldg 106,Univ St,POB 2713, Doha, Qatar
[2] Jordan Univ Sci & Technol, Dept Nutr & Food Technol, Irbid, Jordan
[3] Univ Jordan, Dept Clin Nutr & Dietet, Amman, Jordan
[4] Amer Univ Sci & Technol, Dept Nutr & Food Sci, Beirut, Lebanon
关键词
BMI; C-reactive protein; diabetes; IL-6; inflammation; obesity; C-REACTIVE PROTEIN; OXIDATIVE STRESS; BODY-FAT; INSULIN-RESISTANCE; TNF-ALPHA; MASS; ADIPOSITY; MELLITUS; OBESITY; HYPERGLYCEMIA;
D O I
10.2147/DMSO.S214426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim: Systemic inflammation is related to the progression of complications associated with diabetes. This study aimed to investigate the association between general and abdominal obesity and inflammation in patients with type-2 diabetes with or without glycemic control. Methods: A total of 198 men (n=73) and women (n=125) diagnosed with type 2 diabetes participated in this study. General obesity markers, body mass index (BMI), and abdominal fat were assessed. Circulating concentrations of glycated hemoglobin (HbA1C), C-reactive protein (CRP), and serum interleukin-6 (IL-6) were determined. Poor glycemic control and good glycemic control were defined as having fasting HbA1C concentrations >= 7% and <7%, respectively. Multivariate adjusted analysis of covariance was used to determine the relation between BMI and abdominal fat and markers of inflammation in patients with good and poor glycemic control. Results: Patients in <7% HbA1C category, those with high abdominal fat had approximate to 262% higher CRP and approximate to 30.6% higher IL-6 compared to those with low abdominal fat (p<0.05). Patients in >= 7% HbA1C category, those with high abdominal fat had approximate to 41.4% higher CRP and approximate to 33.9% higher IL-6 compared to those with low abdominal fat (p<0.05). Abdominal fat was directly related to CRP (p<0.023) and IL-6 (p<0.002) concentrations in both groups of type-2 diabetic patients with <7% and >= 7% HbA1C. In patients with >= 7% HbA1C, BMI was directly related to CRP (p<0.02) and IL-6 (p<0.047). Whereas in patients with <7% HbA1C, BMI was not associated with CRP or IL-6 concentrations. Conclusion: High level of abdominal fat is associated with systemic inflammation in type-2 diabetes regardless of glycemic control. Abdominal fat is a better predictor (determinant) of inflammation than BMI in patients with type-2 diabetes with or without glycemic control.
引用
收藏
页码:2411 / 2417
页数:7
相关论文
共 45 条
[1]   An increase in prevalence of diabetes mellitus in Jordan over 10 years [J].
Ajlouni, Kamel ;
Khader, Yousef S. ;
Batieha, Anwar ;
Ajlouni, Haitham ;
El-Khateeb, Mohammed .
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2008, 22 (05) :317-324
[2]   Truncal fat mass as a contributor to inflammation in end-stage renal disease [J].
Axelsson, J ;
Qureshi, AR ;
Suliman, ME ;
Honda, H ;
Pecoits-Filho, R ;
Heimbürger, O ;
Lindholm, B ;
Cederholm, T ;
Stenvinkel, P .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2004, 80 (05) :1222-1229
[3]   Chronic inflammation, immunosuppression and cancer: New insights and outlook [J].
Baniyash, M .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (01) :80-88
[4]   Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro [J].
Bastard, JP ;
Maachi, M ;
Van Nhieu, JT ;
Jardel, C ;
Bruckert, E ;
Grimaldi, A ;
Robert, JJ ;
Capeau, J ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (05) :2084-2089
[5]   Inflammation, obesity and comorbidities:: the role of diet [J].
Bullo, Monica ;
Casas-Agustench, Patricia ;
Amigo-Correig, Pilar ;
Aranceta, Javier ;
Salas-Salvado, Jordi .
PUBLIC HEALTH NUTRITION, 2007, 10 (10A) :1164-1172
[6]   Oxidative stress status and liver tissue defenses in diabetic rats during intensive subcutaneous insulin therapy [J].
Dal, Stephanie ;
Jeandidier, Nathalie ;
Seyfritz, Elodie ;
Bietiger, William ;
Peronet, Claude ;
Moreau, Francois ;
Pinget, Michel ;
Maillard, Elisa ;
Sigrist, Severine .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2016, 241 (02) :184-192
[7]   The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes [J].
Dandona, P ;
Aljada, A ;
Chaudhuri, A ;
Bandyopadhyay, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (06) :2422-2429
[8]   Mechanisms of β-cell death in type 2 diabetes [J].
Donath, MY ;
Ehses, JA ;
Maedler, K ;
Schumann, DM ;
Ellingsgaard, H ;
Eppler, E ;
Reinecke, M .
DIABETES, 2005, 54 :S108-S113
[9]   The relation of body fat mass and distribution to markers of chronic inflammation [J].
Festa, A ;
D'Agostino, R ;
Williams, K ;
Karter, AJ ;
Mayer-Davis, EJ ;
Tracy, RP ;
Haffner, SM .
INTERNATIONAL JOURNAL OF OBESITY, 2001, 25 (10) :1407-1415
[10]   C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study [J].
Freeman, DJ ;
Norrie, J ;
Caslake, MJ ;
Gaw, A ;
Ford, I ;
Lowe, GDO ;
O'Reilly, DS ;
Packard, CJ ;
Sattar, N .
DIABETES, 2002, 51 (05) :1596-1600